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Introduction
The kidneys play an important role in regulating blood pressure by controlling sodium balance (Guyton, 1989; Guyton, 1991) . Although many systems can influence blood pressure in the short term, the long-term blood pressure setting ultimately depends on renal sodium excretion. In this regard, transporters in the apical and basolateral membranes of epithelial cells in nephrons are responsible for sodium reabsorption and fluid balance and are therefore important candidates for involvement in the development of hypertension (Su and Menon, 2001 ).
The results of renal transplantation experiments in genetically hypertensive and normotensive rat strains are consistent with the concept that the kidneys regulate long-term levels of arterial blood pressure and that a defect in the kidney is importantly involved in the pathogenesis of genetic hypertension (Rettig et al., 1990; Frey et al., 2000; Grisk et al., 2002) .
Moreover, studies using isolated perfused kidneys from spontaneously hypertensive rats (SHR) reveal an intrinsic renal abnormality in Na + excretion that may contribute to the maintenance of hypertension in SHR (Heckmann et al., 1989) . Furthermore, examination of the pressurenatriuresis relationship and the effect of furosemide (an inhibitor of the bumetanide-sensitive Na + -K + -2Cl -cotransporter, also called BSC-1 or NKCC2) on this relationship demonstrates a resetting of the pressure-natriuresis process in SHR by a mechanism involving in part BSC-1 (Raine et al., 1984) .
BSC-1 in the thick ascending limb of Henle's loop mediates reabsorption of approximately 25% of the filtered Na + load and is selectively inhibited by loop diuretics (Russell, JPET #71209 5 of BSC-1 in the thick ascending limb causes sodium retention in rats with congestive heart failure (CHF) (Nielsen et al., 1997) . Moreover, BSC-1 is up-regulated in rats with small to moderate myocardial infarctions (Nogae et al., 2000) , dehydration and cardiac failure (Marumo et al., 1998) . Finally, mutations in the NKCC2 gene, which encodes BSC-1, presumably by inducing a loss of function of the transporter, result in Bartter's syndrome, an inherited disease characterized by hypokalemic metabolic alkalosis, hypercalciuria, salt wasting, and volume depletion resulting in hypotension (Simon et al., 1996; Vargas-Poussou et al., 1998) . Clearly alterations in BSC-1 activity can influence long-term levels of arterial blood pressure.
Because BSC-1 influences arterial blood pressure, it is conceivable that increases in BSC-1 activity and/or expression contribute to genetic hypertension. The expression of BSC-1 in SHR has not been previously examined, but it can be hypothesized that changes in BSC-1 expression may play a critical role in the development of altered sodium handling in the SHR thereby contributing to the pathogenesis of genetic hypertension. Accordingly, in the present study, we determined the expression of BSC-1 protein and mRNA in the outer cortex, inner strip of outer medulla and inner medulla of kidneys obtained from both SHR and Wistar-Kyoto (WKY) normotensive rats. To determine the specificity of any observed changes in BSC-1 expression, we also compared protein expression of the thiazide sensitive Na + -Cl -cotransporter (TSC), the type-3 Na + -H + exchanger (NHE-3), Na + -K + -ATPase-α 1 , the inwardly rectifying K + channel (ROMK-1), the type-1 Na + -HCO 3 --cotransporter (NBC-1), aquaporin-1 and aquaporin-2.
Finally, because we observed a marked increase in the expression of BSC-1 protein in the inner strip of the outer medulla of SHR, we also compared the acute effects of the loop diuretic furosemide on hemodynamics and renal function in SHR versus WKY. 
RNA isolation and RT-PCR
The right kidneys were used for RNA isolation. Kidneys were dissected to obtain outer cortex, inner stripe of outer medulla and inner medulla. RNA was isolated from the dissected tissues using TRIzol reagent (GIBCO Life Technologies, Carlsbad, CA) as per the manufacturer's instructions. By using the primer sequences listed in 
Results
Expression of BSC-1 and TSC proteins
BSC-1 and TSC are sodium transporters that are expressed predominantly in the apical membranes of the thick ascending limbs and distal tubules, respectively. Semi-quantitative immunoblotting showed that the expression of BSC-1 protein was found to be significantly higher in the outer medulla of the SHR compared to WKY (6-fold, p < 0.05; Figure 1 ). We could not detect expression of BSC-1 in the outer cortex and inner medulla of either group. In contrast to BSC-1, TSC protein was expressed primarily in the outer cortex, and the expression in SHR versus WKY was similar ( Figure 1 ). protein in the outer cortex, outer medulla and inner medulla with significantly higher expression in the cortex and inner medulla of SHR kidneys (2-fold, p < 0.05; Figure 2 ). Na + -K + -ATPase-α 1 protein expression was detected in the outer cortex and outer and inner medulla, and Na + -K + -ATPase-α 1 protein expression was significantly, albeit modestly (approximately 25%), higher in the outer and inner medulla of the SHR compared to WKY (p < 0.05; Figure 2 ). We also detected expression of NBC-1 protein, which is localized to basolateral membranes of proximal tubules, in the outer cortex, but not outer or inner medulla, and found the expression of NBC-1 protein to be higher in the outer cortex of the SHR compared to WKY (2-fold, p < 0.05; Figure   3 ).
Expression of NHE-
This article has not been copyedited and formatted. The final version may differ from this version. Expression of ROMK-1 protein in the outer cortex and outer medulla was similar between both groups. However, expression of ROMK-1 in the inner medulla was significantly higher in the SHR compared to WKY (2-fold, p < 0.05; Figure 3 ).
Expression of AQP-1 and AQP-2 proteins
Several studies have demonstrated altered expression and apical targeting of aquaporins in water balance disorders (Nielsen et al., 1997; Bickel et al., 2002) . AQP-1 and AQP-2 protein expression was detected in the outer cortex and outer and inner medulla. The expression of AQP-2 was significantly higher in the inner medulla, but not outer cortex or outer medulla, of the SHR compared to WKY (2-fold, p < 0.05; Figure 4 ). Expression of AQP-1 between both groups was similar in all three kidney regions ( Figure 4 ).
Expression of BSC-1, AQP-2 and ROMK-1 mRNA
To determine whether the increases in BSC-1, AQP-2 and ROMK-1 protein expression were accompanied by similar increases in mRNA expression, we examined the mRNA expression for these proteins in outer cortex, outer medulla and inner medulla using RT-PCR.
This article has not been copyedited and formatted. The final version may differ from this version. RT-PCR demonstrated that levels of BSC-1, ROMK-1 and AQP-2 mRNA in both groups were similar ( Figure 5 ), suggesting that post-transcriptional events are likely to be responsible for the increase in the expression of these proteins.
Effects of BSC-1 inhibition
As a measure of the relative activity of the BSC-1 transporter, we measured the response to low and high doses of furosemide (3 and 50 mg/kg, respectively) in WKY and SHR. 
Discussion
The present study was based on the concept that the pathogenesis of sustained hypertension involves the kidneys. Altered renal sodium handling in the SHR has been previously reported (Roman and Cowley, 1985; Firth et al., 1989) ; however, the factors contributing to this effect are unknown. We have shown through semi-quantitative immunoblotting that the expression of sodium transporters BSC-1, Na-K-ATPase-α1, NHE-3, NBC-1; the potassium channel ROMK-1 and the water channel AQP-2 are elevated in the SHR, suggesting that the pathophysiology of altered renal excretory function in genetic hypertension may involve alterations in several transporters located along the nephron. TSC protein expression was not changed, suggesting that the distal convoluted tubule sodium transport mediated by TSC is not affected in this genetic model of hypertension.
In the present study, expression of BSC-1 protein was elevated in the SHR more so than any other protein examined. This finding suggests that the increase in BSC-1 expression may be In the present study, acute administration of furosemide lowered arterial blood pressure in SHR, but not WKY. Generally, changes in renal excretory function do not alter arterial blood pressure within the time frame of the current study. However, anesthetized rats are much more sensitive to volume depletion. Therefore, it is possible that the acute reduction in blood pressure induced by furosemide in SHR was secondary to more severe volume depletion following furosemide-induced natriuresis. At any rate, it is important to note that despite the greater reduction in renal perfusion pressure (which would tend to attenuate sodium excretion), furosemide still had a greater effect on sodium excretion in SHR.
Importantly, the increase steady state levels of BSC-1, ROMK-1 and AQP-2 proteins in the SHR was not accompanied by an increase in their respective steady state mRNA levels,
suggesting that a post-transcriptional mechanism is responsible for the over-expression of these transporters. In this regard, our findings are consistent with previous reports demonstrating that post-transcriptional mechanisms are responsible for the increase in protein expression and activity of the NHE-3 transporter as well as Na-K-ATPase in the SHR (Hayward et al., 1999; LaPointe et al., 2002) . Whether higher steady state levels of BSC-1, ROMK-1 and AQP-1 in SHR are due to greater translational efficiency or enhanced stability of the proteins or both cannot be deduced from the present study.
Our study is consistent with the idea that an intrinsic abnormality in sodium handling by , 1995) . Thus the increased expression of BSC-1 and aquaporin-2 could well be a vasopressin-mediated response. However, our finding that AQP-2 is only elevated in the inner medulla, not outer medulla, weighs against this conclusion because vasopressin increases AQP-2 expression all along the medullary collecting duct.
The renin-angiotensin system also regulates expression of epithelial transporters and could be involved in upregulation of transporter expression in SHR. Studies by several groups demonstrate that administration of angiotensin II increases BSC-1 expression in rat kidneys (Kwon et al., 2003) and that expression of BSC-1 is reduced in mice lacking angiotensin This article has not been copyedited and formatted. The final version may differ from this version. Prostaglandins may also regulate renal sodium excretion in SHR. Recent studies with cyclooxygenase inhibitors show that COX-2 inhibitors increase BSC-1 expression in rat kidneys, thus implicating a role for prostaglandins in BSC-1 regulation (Fernandez-Llama et al., 1999) .
Although our study demonstrates a role for BSC-1 in hypertension in the SHR, it does not rule out the involvement of other sodium transporters. Previous studies have show that sodium reabsorption in the proximal tubule is also increased in the SHR (Biollaz et al., 1986; Firth et al., 1989) . Studies also show that sodium transporters of the proximal tubule, namely the NHE-3, and Na + -K + -ATPase are upregulated in the SHR kidney (Tsuruya et al., 1991; LaPointe et al., 2002) . Our data are in concordance with these findings. In addition, our studies indicate that expression of the potassium-channel ROMK-1 is also higher in the inner medulla of the SHR.
Thus it appears that the pathophysiology of genetic hypertension is complex and that several transporters located along the nephron may be involved.
As noted above, previous studies clearly indicate that sodium reabsorption in the proximal tubule is increased in the SHR. Thus it is conceivable that the observed increases in BSC-1 expression in the inner strip of the outer medulla (corresponding to the thick ascending example, chronic inhibition of sodium transport in the thick ascending limb with loop diuretics or in the distal convoluted tubules with thiazide diuretics causes a compensatory increase in sodium reabsorption and/or transporters in other nephron segments (Ellison et al., 1989; Abdallah et al., 2001; Na et al., 2003) . This phenomenon provides the basis for the synergy that is achieved when diuretics acting at different nephron segments are combined to provide sequential blockade (Flouvat et al., 1991) . Therefore, it is unlikely that increases in proximal tubule transport would cause increases in BSC-1 expression in the thick ascending limb because the expected response would be a decrease, not an increase, in BSC-1 expression.
In summary, the present study demonstrates a marked increase in the expression of BSC-1 and more modest increases in the expressions of Na-K-ATPase-α1, NHE-3, NBC-1, ROMK-1 and AQP-2 in the SHR kidney. Therefore, dysregulation of the steady state levels of renal epithelial transporters may importantly contribute to the pathogenesis of hypertension in genetic hypertension.
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